| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |